CAR-T and Bispecific Antibodies: Mapping the Disruptive Technologies Fueling Unprecedented Expansion in the Cancer Therapeutics Arena.
The concept of precision medicine—tailoring treatment to the unique genetic profile of a patient’s disease—has become the central pillar of modern oncology, directly influencing the spectacular financial growth of the drugs market. This approach is transforming cancer from a single disease category into hundreds of distinct, treatable molecular ailments. The overall market,...
0 Σχόλια 0 Μοιράστηκε 256 Views 0 Προεπισκόπηση